| P/E (FY) | 29.3 | Sales (TTM) | SEK 1.19B |
| Earnings (TTM) | SEK 203.5M | ROE | 25.25% |
| Net Margin | 17.07% | ROIC | 50.07% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 22.93% |
RaySearch Laboratories AB is a medical technology company providing software for cancer treatment worldwide. Its products include the RayStation treatment planning system, the RayCare oncology information system, the RayIntelligence cloud analytics tool, the RayCommand treatment control system, RayPlan, the DrugLog injectable-verification tool, and machine learning and liver ablation solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
| Market Cap | $614,001 | Trading Days | 4109 |
| 52W High | 365.50 |
| 52W Low | 153.10 |
| % Off High | −52.31% |
| YTD | −21.93% | 1Y | −49.43% |
| 3Y | 159.12% | 5Y | 114.65% |
| 10Y | 35.11% | Since incept. (ann.) | 11.92% |
| Ann. Volatility (1Y) | 50.17% | Ann. Volatility (3Y) | 50.79% |
| Sharpe (1Y) | −1.16 | Sharpe (3Y) | 0.92 |
| Max Drawdown (1Y) | −54.07% | Max Drawdown (3Y) | −54.07% |
| Beta (3Y, vs SPY) | 1.05 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| RBOT | Vicarious Surgical Inc. | $613,065 | — |
| ODYY | Odyssey Health, Inc. | $605,812 | — |
| IMCC | IM Cannabis Corp. | $641,356 | — |
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | $559,394 | — |
| PTIX | Protagenic Therapeutics, Inc.\new | $685,993 | — |
| SSKN | STRATA Skin Sciences, Inc. | $529,938 | — |
| VTAK | Catheter Precision, Inc. | $753,892 | — |
| LYRA | Lyra Therapeutics, Inc. | $887,441 | — |
| AYRWF | Ayr Wellness Inc. | $402,411 | — |
| ZVSA | ZyVersa Therapeutics, Inc. | $939,127 | — |
| ATXI | AVENUE THERAPEUTICS, INC. |
| $988,490 |
| — |
| LIFE.OL | Lifecare ASA | $378,977 | — |
